Hege Hellstrom
Director/Board Member bij VIVESTO AB
Vermogen: 154 254 $ op 31-03-2024
Profiel
Hege Hellstrom is the founder of Belnor BV.
He currently holds the position of Director at Camurus AB, Independent Non-Executive Director at Vivesto AB, Director at Jane Goddall Institute Belgium, Independent Non-Executive Director at InflaRx NV, and Chief Commercial Officer at Advicenne SA. Previously, Hege held the position of General Manager at Genzyme AB, President at Swedish Orphan Biovitrum AB from 2013 to 2018, and Head-Cardiovascular Unit at Sanofi AB.
Hege's education includes an undergraduate degree from Oslo Metropolitan University and Ullevaal School of Bioengineering.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAMURUS AB
0.01% | 15-09-2023 | 3 250 ( 0.01% ) | 154 254 $ | 31-03-2024 |
Actieve functies van Hege Hellstrom
| Bedrijven | Functie | Begin |
|---|---|---|
| VIVESTO AB | Director/Board Member | 26-09-2019 |
| CAMURUS AB | Director/Board Member | 07-05-2020 |
| ADVICENNE | Corporate Officer/Principal | 26-05-2020 |
| INFLARX N.V. | Director/Board Member | 01-04-2023 |
| Belnor BVBA | Founder | - |
| Jane Goddall Institute Belgium | Director/Board Member | - |
Eerdere bekende functies van Hege Hellstrom
| Bedrijven | Functie | Einde |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | President | 01-01-2018 |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Corporate Officer/Principal | - |
Genzyme AB
 Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
Opleiding van Hege Hellstrom
| Oslo Metropolitan University | Undergraduate Degree |
| Ullevaal School of Bioengineering | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| CAMURUS AB | Health Technology |
| VIVESTO AB | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| ADVICENNE | Health Technology |
| INFLARX N.V. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme AB
Genzyme AB Pharmaceuticals: MajorHealth Technology Genzyme AB develops and manufactures specialty therapeutic, surgical and diagnostic products. The firm focuses specifically on these areas, has evolved over the years to include immune disorders, cardiovascular diseases, stem cell mobilization and other areas where the lack of adequate treatment. The company was founded in 1981 and is headquartered in Stockholm, Sweden. | Health Technology |
Sanofi AB
Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Distribution Services |
| Belnor BVBA | |
| Jane Goddall Institute Belgium |
